Statistics
Total Visits
| Views | |
|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 529 |
Total Visits Per Month
| December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | |
|---|---|---|---|---|---|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 22 | 31 | 32 | 28 | 41 | 59 | 43 |
File Visits
| Views | |
|---|---|
| Registro IRESP.PROB 2.pdf | 202 |
Top country views
| Views | |
|---|---|
| United States | 140 |
| Germany | 71 |
| Singapore | 62 |
| Hong Kong | 44 |
| Brazil | 35 |
| Ireland | 22 |
| United Kingdom | 20 |
| Vietnam | 17 |
| Spain | 14 |
| Japan | 12 |
Top cities views
| Views | |
|---|---|
| Frankfurt am Main | 67 |
| Ashburn | 54 |
| Hong Kong | 43 |
| Dublin | 22 |
| Council Bluffs | 16 |
| San Jose | 14 |
| Singapore | 12 |
| Seoul | 8 |
| Santafé | 7 |
| Hanoi | 6 |
